Character of ocular surface mucins and their alteration in dry eye disease

Ocular Surface

Volumn 2, Issue 2, 2004, Pages 131-148

  Gipson, Ilene K ^a   Hori, Yuichi ^a   Argüeso, Pablo ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Dry eye; Epithelia; Epithelial mucins; MUC1; MUC16; MUC4; MUC5AC; Mucins; Ocular surface

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ANTIINFLAMMATORY AGENT; ARTIFICIAL TEAR; COMPLEMENTARY DNA; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; DEXAMETHASONE; DIQUAFOSOL; EYE PROTEIN; FLUOROMETHOLONE; FLURIBIPROFIN; GEFARNATE; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MUCIN; MUCIN 1; MUCIN 2; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 6; MUCIN 7; PURINE P2Y2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RETINOIC ACID; RETINOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIDINE DIPHOSPHATE; WATER;

CHROMOSOME ANALYSIS; CHROMOSOME MAP; CLINICAL TRIAL; CONJUNCTIVA EPITHELIUM; CORNEA EPITHELIUM; CYTOLOGY; DRUG EFFICACY; DRY EYE; ENZYME GLYCOSYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE DISEASE; GENE CONTROL; GENE FUNCTION; GENETIC ANALYSIS; GLYCOCALYX; GOBLET CELL; HUMAN; HYDROPHILICITY; IMMUNOBLOTTING; IMMUNOLOCALIZATION; IN SITU HYBRIDIZATION; LACRIMAL GLAND; MUCOUS MEMBRANE PEMPHIGOID; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; TEAR FILM;

EID: 24644453661     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70149-0     Document Type: Review

References (124)

1. Gendler SJ, Spicer AP. Epithelial mucin genes. Annu Rev Physiol. 1995;57:607-34
2. Moniaux N, Escande F, Porchet N, et al. Structural organization and classification of the human mucin genes. Front Biosci 2001;6:D1192-206
3. Fleiszig SM, Zaidi TS, Ramphal R, Pier GB. Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus. Infect Immun 1994;62:1799-1804
4. Gipson IK, Argueso P. The role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol 231:1-49
5. Sellers LA, Allen A, Morris ER, Ross-Murphy SB. The rheology of pig small intestinal and colonic mucus: weakening of gel structure by non-mucin components. Biochim Biophys Acta 1991;1115:174-179
6. Desseyn JL, Buisine MP, Porchet N, et al. Evolutionary history of the 11p15 human mucin gene family. J Mol Evol 1998;46:102-6
7. Desseyn JL, Aubert JP, Porchet N, Laine A. Evolution of the large secreted gel-forming mucins. Mol Biol Evol 2000;17:1175-84
8. Inatomi T, Spurr-Michaud S, Tisdale AS, et al. Expression of secretory mucin genes by human conjunctival epithelia. Invest Ophthalmol Vis Sci 1996;37:1684-92
9. Godl K, Johansson ME, Lidell ME, et al. The N terminus of the MUC2 mucin forms thrimers that are held together within a Trypsin-resistant core fragment. J Biol Chem 2002;277:47248-56
10. Perez-Vilar J, Hill RL. The structure and assembly of secreted mucins. J Biol Chem 1999;274:31751-4
11. Lapensee L, Paquette Y, Bleau G. Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9). Fertil Steril 1997;68:702-8
12. Bobek LA, Tsai H, Biesbrock AR, Levine MJ. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem 1993;268: 20563-9
13. Nielsen PA, Bennett EP Wandall HH, et al. Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B. Glycobiology 1997;7:413-9
14. Sharma P, Dudus L, Nielsen PA, et al. MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol 1998;19:30-7
15. Jumblatt MM, McKenzie RW, Steele PS, et al. MUC7 expression in the human lacrimal gland and conjunctiva. Cornea 2003;22:41-5
16. Bramwell ME, Wiseman G, Shotton DM. Electron-microscopic studies of the CA antigen, epitectin. J Cell Sci 1986;86:249-61
17. Williams SJ, McGuckin MA, Gotley DC, et al. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 1999;59:4083-9
18. Pratt WS, Crawley S, Hicks J, et al. Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. Biochem Biophys Res Commun 2000;275:916-23
19. Gum JR Jr, Crawley SC, Hicks JW et al. MUC17, a novel membrane-tethered mucin. Biochem Biophys Res Commun 2002;291:466-75
20. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 2001;6:339-53
21. Carraway KL, Price-Schiavi SA, Komatsu M, et al. Multiple facets of sialomucin complex/MUC4, a membrane mucin and erbB2 ligand, in tumors and tissues (Y2K update). Front Biosci 2000;5:D95-D107
22. Komatsu M, Carraway CA, Fregien NL, Carraway KL. Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex. J Biol Chem 1997;272:33245-54
23. Parry G, Beck JC, Moss L, et al. Determination of apical membrane polarity in mammary epithelial cell cultures: the role of cell-cell, cell-substratum, and membrane-cytoskeleton interactions. Exp Cell Res 1990;188:302-11
24. Yamamoto M, Bharti A, Li Y, Kufe D. Interaction of the DF3/ MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. J Biol Chem 1997;272:12492-4
25. Zrihan-Licht S, Baruch A, Elroy-Stein O, et al. Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules. FEBS Lett 1994;356:130-6
26. Li Y, Liu D, Chen D, et al. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene 2003;22:6107-10
27. Lloyd KO, Yin BW. Synthesis and secretion of the ovarian cancer antigen CA 125 by the human cancer cell line NIH:OVCAR3. Tumour Biol 2001;22:77-82
28. Williams SJ, Wreschner DH, Tran M, et al. Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem 2001;276:18327-36
29. Carraway KL, Ramsauer VP, Haq B, et al. Cell signaling through membrane mucins. Bioessays 2003;25:66-71
30. Higuchi T, Orita T, Nakanishi S, et al. Molecular cloning, genomic structure and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J Biol Chem 2004;279:1968-79
31. Ligtenberg MJ, Kruijshaar L, Buijs F, et al. Cell-associated episialin is a complex containing two proteins derived from a common precursor. J Biol Chem 1992;267:6171-7
32. Rossi EA, McNeer RR, Price-Schiavi SA, et al. Sialomucin complex, a heterodimeric glycoprotein complex. Expression as a soluble, secretable form in lactating mammary gland and colon. J Biol Chem 1996;271:33476-85
33. Sheng Z, Hull SR, Carraway KL. Biosynthesis of the cell surface sialomucin complex of ascites; 13762 rat mammary adenocarcinoma cells from a high molecular weight precursor. J Biol Chem 1990;265:8505-10
34. Auersperg N, Pan J, Grove BD, et al. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci U S A. 1999;96:6249-54
35. Wreschner DH, McGuckin MA, Williams SJ, et al. Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins. Protein Sci 2002;11:698-706
36. Parry S, Silverman HS, McDermott K, et al. Identification of MUC1 proteolytic cleavage sites in vivo. Biochem Biophys Res Commun 2001;283:715-20
37. Khatri IA, Wang R, Forstner JF. SEA (sea-urchin sprerm protein, enterokinase and agrin) module cleavage, association of fragments and membrane targeting of rat intestinal mucin Muc3. Biochem J 2003;373(Pt 3):893-900
38. Wreschner DH, Hareuveni M, Tsarfaty I, et al. Human epithelial tumour antigen cDNA sequences. Differential splicing may generate multiple protein forms. Eur J Biochem 1990;189:463-73
39. Yin BW Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem 2001;276:27371-5
40. McKenzie RW, Jumblatt JE, Jumblatt MM. Quantification of MUC2 and MUC5AC transcripts in human conjunctiva. Invest Ophthalmol Vis Sci 2000;41:703-8
41. Kessing SV. Mucous gland system of the conjunctiva. A quantitative normal anatomical study. Acta Ophthalmol (Copenh) 1968;Suppl 95:1-133
42. Argueso P, Balaram M, Spurr-Michaud S, et al. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci 2002;43:1004-11
43. Inatomi T, Tisdale AS, Zhan Q, et al. Cloning of rat Muc5AC mucin gene: comparison of its structure and tissue distribution to that of human and mouse homologues. Biochem Biophys Res Commun 1997;236:789-97
44. Argueso P, Gipson IK. Epithelial mucins of the ocular surface: structure, biosynthesis; and function. Exp Eye Res 2001;73:281-9
45. Inatomi T, Spurr-Michaud S, Tisdale AS, Gipson IK. Human corneal and conjunctival epithelia express MUC1 mucin. Invest Ophthalmol Vis Sci 1995;36:1818-27
46. Argueso P, Spurr-Michaud S, Russo CL, et al. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. Invest Ophthalmol Vis Sci 2003;44:2487-95
47. Pflugfelder SC, Liu Z, Monroy D, et al. Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid. Invest Ophthalmol Vis Sci 2000;41:1316-26
48. Gipson IK. In situ hybridization techniques for localizing mucin mRNA. Methods Mol Biol. 2000;125:323-36
49. Danjo Y, Watanabe H, Tisdale AS, et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci 1998;39:2602-9
50. Arango ME, Li P, Komatsu M, et al. Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland. Invest Ophthalmol Vis Sci 2001;42:2749-56
51. Seifert P, Spitznas M, Koch F, Cusamano A. Light and electron microscopic morphology of accessory lacrimal glands, in Sullivan DA, (ed) Lacrimal gland, tear film, and dry eye syndromes: Basic science and clinical relevance. New York, Plenum Press, 1994, pp 19-23
52. Nichols BA, Chiappino ML, Dawson CR. Demonstration of the mucous layer of the tear film by electron microscopy. Invest Ophthalmol Vis Sci 1985;26:464-73
53. Watanabe H, Fabricant M, Tisdale AS, et al. Human corneal and conjunctival epithelia produce a mucin-like glycoprotein for the apical surface. Invest Ophthalmol Vis Sci 1995;36:337-44
54. Prydal JI, Campbell FW. Study of precorneal tear film thickness and structure by interferometry and confocal microscopy. Invest Ophthalmol Vis Sci 1992;33:1996-2005
55. Prydal JI, Artal P, Woon H, Campbell FW. Study of human precorneal tear film thickness and structure using laser interferometry. Invest Ophthalmol Vis Sci 1992;33:2006-11
56. Pfister RR, Burstein NL. The normal and abnormal human corneal epithelial surface: a scanning electron microscope study. Invest Ophthalmol Vis Sci 1977;16:614-22
57. Gipson IK, Yankauckas M, Spurr-Michaud SJ, et al. Characteristics of a glycoprotein in the ocular surface glycocalyx. invest Ophthalmol Vis; Sci 1992;33:218-27
58. Thatcher RW, Darougar S, Jones BR. Conjunctival impression cytology. Arch Ophthalmol 1977;95:678-81
59. Danjo Y, Gipson IK. Actin "purse string" filaments are anchored by E-cadherin-mediated adherens junctions at the leading edge of the epithelial wound, providing coordinated cell movement. J Cell Sci 1998;111:3323-32
60. Pisella PJ, Brignole F, Debbasch C, et al. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. Ophthalmology 2000;107:1841-9
61. Corrales R, Calonge M, Herreras J, et al. Levels of mucin gene expression in normal human conjunctival epithelium in vivo. Curr Eye Res 2003;27:323-8
62. Pflugfelder SC, Tseng SC, Yoshino K, et al. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology 1997;104:223-35
63. Zhao H, Jumblatt JE, Wood TO, Jumblatt MM. Quantification of MUC5AC protein in human tears. Cornea 2001;20:873-7
64. Jumblatt JE, Cunningham LT, Li Y, Jumblatt MM. Characterization of human ocular mucin secretion mediated by 15(S)-HETE. Cornea 2002;21:818-24
65. Real FX, de Bolos C, Oosterwijk E. Polyclonal and monoclonal techniques. Methods Mol Biol 2000;125:353-68
66. Walsh MD, Jass JR. Histologically based methods for detection of mucin. Methods Mol Biol 2000;125:29-44
67. Ralph RA. Conjunctival goblet cell density in normal subjects and in dry eye syndromes. Invest Ophthalmol Vis Sci 1975;14:299-302
68. Nelson JD, Havener VR, Cameron JD. Cellulose acetate impressions of the ocular surface. Dry eye states. Arch Ophthalmol 1983;101:1869-72
69. Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol 2002;120:330-7
70. Dohlman CH, Friend J, Kalevar V, et al. The glycoprotein (mucus) content of tears from normals and dry eye patients. Exp Eye Res 1976;22:359-65
71. Kinoshita S, Kiorpes TC, Friend J, Thoft RA. Goblet cell density in ocular surface disease. A better indicator than tear mucin. Arch Ophthalmol 1983;101:1284-7
72. Tei M, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Vitamin A deficiency alters the expression of mucin genes by the rat ocular surface epithelium. Invest Ophthalmol Vis Sci 2000;41:82-8
73. Wandall HH, Hassan H, Mirgorodskaya E, et al. Substrate specificities of three members of the human UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem 1997;272:23503-14
74. Argueso P, Tisdale A, Mandel U, et al. The cell-layer- and cell-type-specific distribution of GaINAc-transferases in the ocular surface epithelia is altered during keratinization. Invest Ophthalmol Vis Sci 2003;44:86-92
75. Paulson JC, Colley KJ. Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem 1989;264:17615-8
76. Hounsell EF, Davies MJ, Renouf DV. O-linked protein glycosylation structure and function. Glycoconj J 1996;13:19-26
77. Berry M, Ellingham RB, Corfield AP. Polydispersity of normal human conjunctival mucins. Invest Ophthalmol Vis Sci 1996;37:2559-71
78. Versura P, Maltarello MC, Cellini M, et al. Detection of mucus glycoconjugates in human conjunctiva by using the lectin-colloidal gold technique in TEM. II. A quantitative study in dryeye patients. Acta Ophthalmol (Copenh) 1986;64:451-5
79. Garcher C, Bron A, Baudouin C, et al. CA 19-9 ELISA test: a new method for studying mucus changes in tears. Br J Ophthalmol 1998;82:88-90
80. Jones DT, Monroy D, Ji Z, et al. Sjogren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci 1994;35:3493-504
81. Brignole F, Pisella PJ, Goldschild M, et al. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000;41:1356-63
82. Brignole F, Pisella PJ, De Saint Jean M, et al. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci 2001;42:90-5
83. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye. Invest Ophthalmol Vis Sci 2002;43:2609-14
84. Koo J, Lee J. Cyclosporine: what clinicians need to know. Dermatol Clin 1995;13:897-907
85. Zhao JC, Jin XY. Local therapy of corneal allograft rejection with cyclosporine. Am J Ophthalmol 1995;119:189-94
86. Zhao JC, Jin XY. Immunological analysis and treatment of Mooren's ulcer with cyclosporin A applied topically. Cornea 1993;12:481-8
87. Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Ophthalmology 2000;107:967-74
88. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107:631-9. Erratum in Ophthalmology 2000;107:1220
89. Kunert KS, Tisdale AS, Stern ME, et al. Analysis of topical cyclosporine treatment of patients with dry eye syndrome. Effect on conjunctival lymphocytes. Arch Ophthalmol 2000;118:1489-96
90. Burnstock G, Williams M. P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 2000;295:862-9
91. Cowlen MS, Zhang VZ, Warnock L, et al. Localization of ocular P2Y2 receptor gene expression by in situ hybridization. Exp Eye Res 2003;77:77-84
92. Jumblatt JE, Jumblatt MM. Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva. Exp Eye Res 1998;67:341-6
93. Abdullah LH, Conway-JD, Cohn JA, Davis CW. Protein kinase C and Ca2+ activation of mucin secretion in airway goblet cells. Am J Physiol 1997;273:L201-10
94. Fujihara T, Murakami T, Fujita H, et al. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci 2001;42:96-100
95. Jackson RS 2nd, Van Dyken SJ, McCartney MD, Ubels JL. The eicosanoid, 15-(S)-HETE, stimulates secretion of mucin-like glycoprotein by the corneal epithelium. Cornea 2001;20:516-21
96. Marom Z, Shelhamer JH, Kaliner M. Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro. J Clin Invest 1981;67:1695-1702
97. Marom Z, Shelhamer JH, Sun F, Kaliner M. Human airway monohydroxyeicosatetraenoic acid generation and mucus release. J Clin Invest 1983;72:122-7
98. Jumblatt. JE, Cunningham L, Jumblatt MM. Effects of 15(S)-HETE on human conjunctival mucin secretion. Adv Exp Med Biol 2002;506:323-7
99. Nakamura M, Endo K, Nakata K, Hamano T. Gefarnate stimulates secretion of mucin-like glycoproteins by corneal epithelium in vitro and protects corneal epithelium from desiccation in vivo. Exp Eye Res 1997;65:569-74
100. Nakamura M, Endo K, Nakata K, Hamano T. Gefarnate increases PAS positive cell density in rabbit conjunctiva. Br J Ophthalmol 1998;82:1320-3
101. Toshida H, Nakata K, Hamano T, et al. Effect of gefarnate on the ocular surface in squirrel monkeys. Cornea 2002;21:292-9
102. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 1999;106:811-6
103. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 2003;136:593-602
104. Gipson IK, Spurr-Michaud S, Argueso P, et al. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci 2003;44:2496-506
105. Fox RI, Chan R, Michelson JB, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984;27:459-61
106. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999;83:390-5
107. Hori Y, Spurr-Michaud S, Russo C, et al. Differential regulation of membrane-associated mucins in the human ocular surface epithelium. Invest Ophthalmol Vis Sci 2004;45:114-22
108. Sommer A. Vitamin A deficiency and xerophthalmia. Arch Ophthalmol 1990;108:343-4
109. Herbort CP, Zografos L, Zwingli M, Schoeneich M. Topical retinoic acid in dysplastic and metaplastic keratinization of corneoconjunctival epithelium. Graefes Arch Clin Exp Ophthalmol 1988;226:22-6
110. Soong HK, Martin NF, Wagoner MD, et al. Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study. Ophthalmology 1988;95:1442-6
111. Gilbard JP, Huang AJ, Belldegrun R, et al. Open-label crossover study of vitamin A ointment as a treatment for keratoconjunctivitis sicca. Ophthalmology 1989;96:244-6
112. Gendler SJ, BurcheIl JM, Duhig T, et al. Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc Natl Acad Sci U S A 1987;84:6060-4
113. Lan MS, Batra SK, Qi WN, et al. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem 1990;265:15294-9
114. Gum JR, Byrd JC, Hicks JW, et al. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem 1989;264:6480-7
115. Gum JR, Hicks JW, Swallow DM, et al. Molecular cloning of cDNAs; derived from a novel human intestinal mucin gene. Biochem Biophys Res Commun 1990;171:407-15
116. Porchet N, Nguyen VC, Duffosse J, et al. Molecular cloning and chromosomal localization of a novel human tracheobronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem Biophys Res Commun 1991;175:414-22
117. Meerzaman D, Charles P, Daskal E, et al. Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5). J Biol Chem 1994;269:12932-9
118. Guyonnet Duperat V, Audie JP, Debailleul V, et al. Characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes? Biochem J 1995;305:211-9
119. Dufosse J, Porchet N, Audie JP, et al. Degenerate 87-base-pair tandem repeats create hydrophilic/hydrophobic alternating domains in human mucin peptides mapped to 11p15. Biochem J 1993;293:329-37
120. Toribara NW, Roberton AM, Ho SB, et al. Human gastric mucin: identification of a unique species by expression cloning. J Biol Chem 1993;268:5879-85
121. Shankar V, Gilmore MS, Elkins RC, Sachdev GP. A novel human airway mucin cDNA encodes a protein with unique tandem-repeat organization. Biochem J 1994;300:295-8
122. Arias EB, Verhage HG, Jaffe RC. Complementary deoxyribonucleic acid cloning and molecular characterization of an estrogen-dependent human oviductal glycoprotein. Biol Reprod 1994;51:685-94
123. Pallesen LT, Berglund L, Rasmussen LK, et al. Isolation and characterization of MUC15, a novel cell membrane-associated mucin. Eur J Biochem 2002;269:2755-63
124. Chen Y, Zhao YH, Kalaslavadi TB, et al. Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. Am J Respir Cell Mol Biol 2004;30:155-65